4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-22-026341
President and CEO acquired 33,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mack David Henry President and CEO | 2022-04-27 | Option exercise | +33,000 | $0.53 | $17,490 | 79,970 | D |
| Derivatives | |||||||
| Mack David Henry President and CEO | 2022-04-27 | Option exercise · Employee Stock Option (right to buy) | −33,000 | 393,366 | D | ||
Loading xslF345X03/doc4.xml…